American Antitrust Institute Successfully Opposes Drug Makers’ Attempts to Enjoin New California Law Outlawing Pay-for-Delay Drug Settlements

Lieff Cabraser serves as counsel for amicus AAI, who successfully secured denial of drug makers’ requested injunction against the new pro-competition law AB 824 Lieff Cabraser serves as counsel for amicus American Antitrust Institute, on whose behalf the firm filed a brief in opposition to drug makers’ attempts to enjoin a new California law (AB

2019-12-31T14:47:16+00:00December 31st, 2019|Amicus, Antitrust|

Lieff Cabraser Announces Settlement of Lovenox/Enoxaparin Drug Antitrust Class Action with Momenta and Sandoz

$120 million aggregate settlement will benefit hospitals, insurers and companies that pay for their employees’ healthcare costs, and uninsured people affected by the pharma companies’ alleged anticompetitive conduct Lieff Cabraser is proud to announce that Momenta Pharmaceuticals, Inc. and Sandoz Inc. have agreed to settlements totaling $120 million in the antitrust class action about enoxaparin,

2019-12-22T14:23:27+00:00December 22nd, 2019|Antitrust|

Plaintiffs Secure $35M Settlement With Momenta Pharma in Lovenox Blood Clot Drug Antitrust Class Action

As reported by Law360 (subscription), the parties in the Lovenox/Enox blood clot drug antitrust lawsuit have announced a $35 million settlement in the class action lawsuit brought on behalf of thousands of buyers of generic Lovenox (enoxaparin) that accused the company and Sandoz Pharmaceuticals of illegally conspiring to prevent other drug companies from competing in the

2019-12-12T12:44:18+00:00December 12th, 2019|Antitrust, Firm News|

Dean Harvey Speaks at U.S. Justice Department Antitrust Division’s Public Workshop on Competition in Labor Markets

On September 23, 2019, Lieff Cabraser partner Dean M. Harvey participated in a public panel discussion presented by the Antitrust Division of the U.S. Department of Justice on “Competition in Labor Markets” at the DOJ Conference Center in Washington, D.C. The event featured a group of well-known antitrust and competition lawyers, experts, and scholars.

2019-11-18T10:46:37+00:00November 18th, 2019|Antitrust, Firm News|

Lieff Cabraser Duke/UNC “No Poach” Case Team Receives Antitrust Institute’s 2019 Private Enforcement Award

At its annual Antitrust Enforcement Awards dinner in Washington, D.C., the American Antitrust Institute formally presented its selection of leading legal practitioners and economists to be recognized as honorees for the 2019 Antitrust Enforcement Awards, a list that includes the Lieff Cabraser team that worked on the Duke/UNC case: Dean M. Harvey, Kelly M. Dermody, Brendan P. Glackin,

2022-09-21T17:45:38+00:00November 13th, 2019|Antitrust, Awards, Firm News|

Lieff Cabraser Duke/UNC “No Poach” Case Team to Receive Antitrust Institute’s 2019 Private Enforcement Award

The American Antitrust Institute has announced its selection of leading legal practitioners and economists to be recognized as honorees for the 2019 Antitrust Enforcement Awards, a list that includes the Lieff Cabraser team that worked on the Duke/UNC case: Dean M. Harvey, Kelly M. Dermody, Brendan P. Glackin, and Anne B.

2022-09-21T17:46:06+00:00October 15th, 2019|Antitrust, Awards, Firm News|

Final Approval Granted to $54.5m Duke/UNC “No Poach” Antitrust Case Settlement

On September 24, 2019, the U.S. District Court Judge Catherine C. Eagles granted final approval to the proposed settlement of the Duke/UNC “No Poach” case valued at $54.5 million. The settlement includes an unprecedented role for the United States Department of Justice to monitor and enforce extensive injunctive relief. Assistant Attorney General Delrahim remarked: “Permitting the

2019-09-29T12:33:20+00:00September 29th, 2019|Antitrust|

Lieff Cabraser Named Class Counsel in Now-Certified Lovenox Antitrust Class Action Against Momenta & Sandoz

Case alleges Momenta and Sandoz conspired to monopolize the production and distribution of enoxaparin, a generic version of the blood clot drug Lovenox As reported by Law360, Chief Judge Waverly D. Crenshaw, Jr. of the United States District Court for the Middle District of Tennessee has certified a class of thousands of buyers of generic

2019-09-20T19:41:40+00:00September 20th, 2019|Antitrust|

Dean Harvey to Speak at Antitrust Division of Justice Department’s Public Workshop on Competition in Labor Markets

On Monday, September 23, 2019, Lieff Cabraser partner Dean M. Harvey will participate in a panel discussion at the Antitrust Division of the Justice Department’s public workshop on “Competition in Labor Markets” at the DOJ Conference Center in Washington, D.C. The event will feature a number of well-known antitrust and competition lawyers, experts, and scholars.

2019-09-19T14:55:31+00:00September 19th, 2019|Antitrust, Firm News|

$54.5 Million Settlement Proposed in Duke/UNC “No Poach” Employee Anticompetition Lawsuit

On May 20, 2019, a settlement valued at $54.5 million was filed in the class action lawsuit against Duke University over an alleged illegal employee-poaching agreement with the University of North Carolina. The proposed settlement came on the same day that the U.S. Department of Justice decided to intervene in the suit by filing a

2019-05-24T13:28:54+00:00May 24th, 2019|Antitrust, Employment Law|

Title